IL-2– and IL-15–induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+T lymphocytes

MLA

Marzec, Michal, et al. “IL-2– and IL-15–induced Activation of the Rapamycin-Sensitive MTORC1 Pathway in Malignant CD4+T Lymphocytes.” Blood, vol. 111, no. 4, Feb. 2008, pp. 2181–89. EBSCOhost, https://doi.org/10.1182/blood-2007-06-095182.

APA

Marzec, M., Liu, X., Kasprzycka, M., Witkiewicz, A., Raghunath, P. N., El-Salem, M., Robertson, E., Odum, N., & Wasik, M. A. (2008). IL-2– and IL-15–induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+T lymphocytes. Blood, 111(4), 2181–2189. https://doi.org/10.1182/blood-2007-06-095182

Chicago

Marzec, Michal, Xiaobin Liu, Monika Kasprzycka, Agnieszka Witkiewicz, Puthiyaveettil N. Raghunath, Mouna El-Salem, Erle Robertson, Niels Odum, and Mariusz A. Wasik. 2008. “IL-2– and IL-15–induced Activation of the Rapamycin-Sensitive MTORC1 Pathway in Malignant CD4+T Lymphocytes.” Blood 111 (4): 2181–89. doi:10.1182/blood-2007-06-095182.